LivaNova (LIVN) Competitors $36.79 -0.21 (-0.57%) Closing price 04:00 PM EasternExtended Trading$36.78 -0.01 (-0.01%) As of 04:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LIVN vs. STVN, GKOS, NARI, INSP, BLCO, SLNO, IRTC, TMDX, PRCT, and NVSTShould you be buying LivaNova stock or one of its competitors? The main competitors of LivaNova include Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), Inspire Medical Systems (INSP), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), TransMedics Group (TMDX), PROCEPT BioRobotics (PRCT), and Envista (NVST). These companies are all part of the "medical equipment" industry. LivaNova vs. Stevanato Group Glaukos Inari Medical Inspire Medical Systems Bausch + Lomb Soleno Therapeutics iRhythm Technologies TransMedics Group PROCEPT BioRobotics Envista Stevanato Group (NYSE:STVN) and LivaNova (NASDAQ:LIVN) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, risk, valuation, earnings, community ranking, institutional ownership, analyst recommendations, profitability and media sentiment. Does the media refer more to STVN or LIVN? In the previous week, LivaNova had 4 more articles in the media than Stevanato Group. MarketBeat recorded 10 mentions for LivaNova and 6 mentions for Stevanato Group. LivaNova's average media sentiment score of 1.45 beat Stevanato Group's score of 1.18 indicating that LivaNova is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Stevanato Group 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LivaNova 8 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is STVN or LIVN more profitable? Stevanato Group has a net margin of 10.47% compared to LivaNova's net margin of 1.91%. LivaNova's return on equity of 13.81% beat Stevanato Group's return on equity.Company Net Margins Return on Equity Return on Assets Stevanato Group10.47% 9.86% 5.79% LivaNova 1.91%13.81%7.07% Does the MarketBeat Community favor STVN or LIVN? LivaNova received 374 more outperform votes than Stevanato Group when rated by MarketBeat users. Likewise, 69.71% of users gave LivaNova an outperform vote while only 63.27% of users gave Stevanato Group an outperform vote. CompanyUnderperformOutperformStevanato GroupOutperform Votes3163.27% Underperform Votes1836.73% LivaNovaOutperform Votes40569.71% Underperform Votes17630.29% Which has more risk & volatility, STVN or LIVN? Stevanato Group has a beta of 0.52, indicating that its stock price is 48% less volatile than the S&P 500. Comparatively, LivaNova has a beta of 0.9, indicating that its stock price is 10% less volatile than the S&P 500. Do institutionals and insiders hold more shares of STVN or LIVN? 97.6% of LivaNova shares are held by institutional investors. 0.7% of Stevanato Group shares are held by company insiders. Comparatively, 0.3% of LivaNova shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has preferable valuation and earnings, STVN or LIVN? Stevanato Group has higher earnings, but lower revenue than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStevanato Group$1.10B5.71$157.62M$0.4843.33LivaNova$1.25B1.60$17.55M$1.1432.46 Do analysts recommend STVN or LIVN? LivaNova has a consensus target price of $61.17, indicating a potential upside of 65.32%. Given LivaNova's stronger consensus rating and higher possible upside, analysts plainly believe LivaNova is more favorable than Stevanato Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Stevanato Group 0 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.86LivaNova 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.88 SummaryLivaNova beats Stevanato Group on 14 of the 18 factors compared between the two stocks. Get LivaNova News Delivered to You Automatically Sign up to receive the latest news and ratings for LIVN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LIVN vs. The Competition Export to ExcelMetricLivaNovaElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.01B$3.21B$5.56B$7.82BDividend YieldN/A1.80%5.11%4.22%P/E Ratio88.1015.4222.5718.48Price / Sales1.6052.69395.64103.60Price / Cash11.1544.0938.1834.62Price / Book1.563.526.774.25Net Income$17.55M$94.03M$3.22B$248.23M7 Day Performance-0.70%0.99%1.46%0.89%1 Month Performance-5.20%4.39%3.98%3.53%1 Year Performance-40.91%-18.35%16.14%5.09% LivaNova Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LIVNLivaNova3.8227 of 5 stars$36.79-0.6%$61.17+66.3%-33.6%$2.00B$1.25B87.602,900Upcoming EarningsNews CoveragePositive NewsSTVNStevanato Group1.1526 of 5 stars€21.65-1.0%N/A-25.8%$6.56B$1.10B46.064,650Positive NewsGKOSGlaukos4.8044 of 5 stars$88.17-2.3%$156.17+77.1%-1.7%$4.99B$383.48M-30.72780Earnings ReportAnalyst ForecastNews CoveragePositive NewsGap DownNARIInari MedicalN/A$79.97flat$68.00-15.0%N/A$4.68B$493.63M-59.24800INSPInspire Medical Systems4.8547 of 5 stars$144.74-3.6%$218.90+51.2%-34.4%$4.31B$802.80M83.67760Upcoming EarningsBLCOBausch + Lomb3.7046 of 5 stars$12.05-0.1%$18.82+56.2%-20.4%$4.26B$4.79B-13.2412,500Earnings ReportAnalyst ForecastNews CoverageSLNOSoleno Therapeutics4.6429 of 5 stars$68.93-1.5%$99.63+44.5%+67.6%$3.16BN/A-20.7630Upcoming EarningsPositive NewsIRTCiRhythm Technologies0.9603 of 5 stars$98.63-2.3%$119.73+21.4%-2.5%$3.10B$591.84M-27.101,790News CoverageTMDXTransMedics Group3.1869 of 5 stars$87.72-0.6%$122.70+39.9%-2.3%$2.97B$441.54M93.32210Upcoming EarningsAnalyst ForecastPRCTPROCEPT BioRobotics2.7234 of 5 stars$53.43+0.8%$91.43+71.1%+1.9%$2.93B$224.50M-27.40430Earnings ReportAnalyst RevisionPositive NewsHigh Trading VolumeNVSTEnvista3.9412 of 5 stars$14.88-2.0%$19.96+34.2%-18.3%$2.56B$2.51B-2.2912,700Earnings ReportAnalyst ForecastPositive News Related Companies and Tools Related Companies STVN Alternatives GKOS Alternatives NARI Alternatives INSP Alternatives BLCO Alternatives SLNO Alternatives IRTC Alternatives TMDX Alternatives PRCT Alternatives NVST Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LIVN) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored"I'm risking my reputation on this"I've stayed quiet for too long, but after everything I've uncovered about what's brewing in the 2025 crypto ma...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LivaNova PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share LivaNova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.